NCT00549731

Brief Summary

The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2007

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 26, 2007

Completed
5.6 years until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

10 years

First QC Date

October 15, 2007

Last Update Submit

April 21, 2026

Conditions

Autism Spectrum Disorder

Keywords

autismautisticlanguagedevelopmentdevelopmentalassessment

Study Arms (2)

Healthy individuals

No intervention Healthy participants ages 14-32 for a neuroimaging study.

Individuals with Autism Spectrum Disorder

No intervention ASD participants ages 14-32 for a neuroimaging study.

Eligibility Criteria

Age14 Years - 32 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adult/Pediatric

You may qualify if:

  • Typically-developing, healthy adolescents and adults (ages 14-32)
  • Adolescents and adults with autism spectrum disorder (ages 14-32)

You may not qualify if:

  • Extreme premature birth (\<34 weeks)
  • Known genetic disorders related to autism (e.g. Fragile X)
  • Recent diagnosis of psychosis (within 6 months)
  • Some other psychiatric diagnoses may be excluded following screening (e.g. Tourette's syndrome).
  • Metal implants / permanent retainers / hair dyes with metallic components

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Martinos Center of Biomedical Imaging

Charlestown, Massachusetts, 02129, United States

Location

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic DisorderLanguage

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersCommunicationBehavior

Study Officials

  • Tal Kenet, Ph.D

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 15, 2007

First Posted

October 26, 2007

Study Start

June 1, 2013

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

April 24, 2026

Record last verified: 2026-04

Locations

US(1)